Scilex (SCLXW) Competitors $0.22 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends SCLXW vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, AONC, and WENAWShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), American Oncology Network (AONC), and Anew Medical (WENAW). These companies are all part of the "medical" sector. Scilex vs. 180 Life Sciences 60 Degrees Pharmaceuticals Aclarion Ainos Alpha Tau Medical Alvotech Alvotech American Oncology Network American Oncology Network Anew Medical 180 Life Sciences (NASDAQ:ATNFW) and Scilex (NASDAQ:SCLXW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their community ranking, dividends, profitability, media sentiment, institutional ownership, risk, analyst recommendations, earnings and valuation. Does the media favor ATNFW or SCLXW? In the previous week, Scilex had 4 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for Scilex and 0 mentions for 180 Life Sciences. Scilex's average media sentiment score of 0.88 beat 180 Life Sciences' score of 0.00 indicating that Scilex is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Neutral Scilex Positive Is ATNFW or SCLXW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Scilex N/A N/A N/A Which has higher earnings and valuation, ATNFW or SCLXW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AScilex$50.83MN/AN/AN/AN/A Does the MarketBeat Community believe in ATNFW or SCLXW? 180 Life Sciences and Scilex both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AScilexN/AN/A SummaryScilex beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLXW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLXW vs. The Competition Export to ExcelMetricScilexDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$58.71B$5.14B$9.08BDividend YieldN/A2.45%5.09%4.23%P/E RatioN/A228.0490.0517.18Price / SalesN/A267.741,116.25117.06Price / CashN/A19.3043.1037.85Price / BookN/A3.524.784.78Net IncomeN/A$2.29B$120.31M$225.60M7 Day Performance-21.43%-2.71%-1.92%-1.23%1 Month Performance-18.52%-4.10%13.65%0.46%1 Year Performance-30.16%-3.59%28.34%15.24% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXWScilexN/A$0.22flatN/A-35.3%$0.00$50.83M0.00105ATNFW180 Life SciencesN/A$0.01flatN/A+31.6%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.02-51.0%N/A-56.7%$0.00$502,409.000.002Positive NewsGap DownHigh Trading VolumeACONWAclarionN/A$0.03-23.8%N/A-36.1%$0.00$49,289.000.007Positive NewsGap DownAIMDWAinosN/A$0.03flatN/A-89.6%$0.00$40,633.000.0040News CoverageGap UpDRTSWAlpha Tau MedicalN/A$0.20-20.4%N/A+68.4%$0.00N/A0.0080Positive NewsGap DownALVOWAlvotechN/A$2.78+1.1%N/A+48.5%$0.00$391.87M0.004Gap UpALVOAlvotech2.6676 of 5 stars$12.05+2.1%$18.00+49.4%+6.9%$0.00$93.38M0.001,026AONCWAmerican Oncology NetworkN/A$0.27flatN/AN/A$0.00$1.34B0.001,525AONCAmerican Oncology NetworkN/A$4.68+2.6%N/A-22.5%$0.00$1.34B0.001,520News CoverageWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap Down Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors ACONW Competitors AIMDW Competitors DRTSW Competitors ALVOW Competitors ALVO Competitors AONCW Competitors AONC Competitors WENAW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCLXW) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
